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Aim: Evaluation of energy deposition of protons in human brain and calculation of the
secondary neutrons and photons produced by protons in proton therapy.
Background: Radiation therapy is one of the main methods of treating localized cancer
tumors. The use of high energy proton beam in radiotherapy was proposed almost 60 years
ago.  In recent years, there has been a revival of interest in this subject in the context of radi-
ation therapy. High energy protons suffer little angular deﬂection and have a well-deﬁned
penetration range, with a sharp increase in the energy loss at the end of their trajectories,
namely the Bragg peak.
Materials and methods: A slab head phantom was used for the purpose of simulating proton
therapy in brain tissue. In this study simulation was carried out using the Monte Carlo
MCNPX code.
Results: By using mono energetic proton pencil beams, energy depositions in tissues, espe-
cially inside the brain, as well as estimating the neutron and photon production as a result
of  proton interactions in the body, together with their energy spectra, were calculated or
obtained. The amount of energy escaped from the head by secondary neutrons and photons
was determined.
Conclusions: It was found that for high energy proton beams the amount of escaped energy
by  neutrons is almost 10 times larger than that by photons. We estimated that at 110 MeVbeam energy, the overall proton energy “leaked” from the head by secondary photons and
neutrons to be around 1%.
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cranium, and, ﬁnally, 0.5 cm soft tissue as presented in Fig. 1.
Mass densities and compositions of the organs are given in
Table 1.19reports of practical oncology and 
.  Background
owadays, radiation therapy is one of the three main methods
f treating localized cancer tumors. Photons are the most com-
on  type of particles in radiotherapy.1 Despite major technical
evelopments,2 the exponential decrease in the number of
rimary photons remains the main problem due to the nature
f photon interactions in matter. Thus, photons have no
ell-deﬁned range and their dose proﬁles diminish exponen-
ially. So, a considerable dose is received by healthy organs,
efore and after the tumor. Unlike photons, charged particles
ave relatively well-deﬁned penetration range. The dominant
echanism by which charged particles lose their energies is
nelastic interaction with the atomic electrons. They lose most
f their energies near the end of their paths, at the so called
ragg peak.3,4
Beside coulomb interaction with atomic electrons and
lastic nuclear scattering, protons moving inside the mat-
er undergo inelastic nuclear interactions in which secondary
articles, such as neutrons, photons, secondary protons,
euterons, are produced.3 In the energy range used for proton
herapy, neutrons and photons are the most important sec-
ndary particles, in a sense that they can travel far distances
rom the target tissue and store their energies in other organs,
hereby increasing the risk of secondary cancers.5,6
Secondary particles in hadron therapy have two different
rigins:
 First, those produced in the delivery system placed before
particles enter the body. These can mostly be avoided by
proper shielding.
 Second, those produced inside the body itself due to the
interactions of incident particles with the body tissues,
which cannot be eliminated with mechanical techniques.
Therefore, their ﬂux and energy deposition have to be cal-
culated in order to estimate the risk of secondary cancers.
Quite numerous studies, with both Monte Carlo (MC) and
xperimental methods, have dealt with this issue.6–10 Mea-
ured neutron doses from clinical proton facilities vary greatly,
artly as a result of different measurement techniques, and
artly as a result of different beam geometries.11
Kim et al.12 compared secondary radiation doses from IMRT
nd proton beam therapy for lung and liver cancers using
on chamber and CR-39 detectors. They declared that the
econdary dose per treatment Gy for proton beam therapy
anges from 0.17 to 0.086 mGy  at 20–50 cm from the isocenter,
hereas, it ranges from 5.8 to 1.0 mGy  for IMRT.  The internal
eutron dose is much lower, ranging from 0.03 to 0.008 mGy.
he dose due to the secondary neutrons and photons was esti-
ated with Monte Carlo simulation for three existing proton
herapy facilities by Agosteo et al.10 They indicated that the
ose from secondary particle for passive systems is 10 times
igher than that for active systems. Paganetti et al.6 used
he Geant4 toolkit to simulate the proton beam line at MGH
roton therapy center in order to estimate neutron doses to
rgans which are out-of-ﬁeld. They divided the neutron dose
nto internal part, due to proton interactions in the body, and
xternal part, due to proton interactions with components oftherapy 1 9 ( 2 0 1 4 ) 376–384 377
the delivery system. Brenner and Hall11 estimated neutron
equivalent doses to relevant organs, based on the neutron
doses reported by Paganetti et al., considering a conserva-
tive estimate of 25 for low-dose RBE. Then, they used these
organ-speciﬁc equivalent doses to calculate lifetime cancer
risks, using standard techniques which were described in the
US National Academy of sciences BIER-VII report, and other
radiation risk reports.13–15 They estimated the overall lifetime
cancer risk for a 15-year-old boy at about 4.7% and for a 15-
year-old girl at about 11.1%. They indicated it to be larger for
a younger patient and smaller for an older patient.
2.  Aim
In this study we  evaluated the energy deposition of the proton
beam in the human brain phantom, and calculated the sec-
ondary neutrons and photons produced by protons. A good
knowledge on pristine depth and lateral dose proﬁles in the
target volume is necessary to choose a reasonable beam dis-
placement to have a good conformation with the shape of
the tumor, and spare the normal tissues.16 Traditionally, dose
calculations and TPS (treatment planning systems) in hadron
therapy are, mostly, done in water17 due to its proximity to
soft tissues. To be more  precise, it would be better to take
into account the exact composition and sequence of different
tissues.18 This, indeed, is the main task of this work.
3.  Materials  and  methods
3.1.  Head  phantom
The simpliﬁed head phantom was modeled. The tissue prop-
erties, from up to down, in vertical direction are 0.2 cm human
skin, 0.3 cm soft tissue, 0.9 cm cranium, 11.5 cm brain, 0.9 cmFig. 1 – Geometry of the slab head phantom.
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Table 1 – Mass density and elemental composition of the tissues in the head phantom (compositions are expressed as
percentage by weight19).
Tissue type Density (g/cm3) H C N O Ca Na P S Cl K
Skin 1.09 10 20.4 4.2 64.5 – 0.2 0.1 0.2 0.3 0.1
.7 
.0
.2 Soft tissue 1.03 10.5 25.6 2
Cranium 1.61 5 21.2 4
Brain 1.04 10.7 14.5 2
Here, the lateral dimensions of the phantom were consid-
ered in accordance with the maximum values of the brain in
the MIRD-ORNL phantom as 17.2 cm × 13.2 cm.20 Mono ener-
getic proton pencil beams perpendicular to the layers and
toward the bottom of phantom were used, as showed in Fig. 1.
3.2.  Beam  conﬁguration
PBS (pencil beam scanning) system requires less material in
the beam line; range modulator wheel, patient-speciﬁc aper-
ture, and compensator are not required. This substantially
reduces the secondary particle production in the beam line.
Thus, for pencil beam scanning systems the major source
of secondary particles is the interaction of primary protons
inside the patient, and not in the delivery system.21 As the
goal of this study, we  investigated the energy deposition and
secondary particle production inside the head phantom, we
considered a simple pencil beam that is the outlet of a typical
spot scanning delivery system. Here, we concentrated only on
the interaction of the proton beam with the body tissues, and,
therefore, the real beam line conﬁguration did not matter. The
beam in accordance with some active beam line facilities3,22,23
is considered to have 7 mm of FWHM at the skin surface.
The energy deposition and also absorbed dose were calcu-
lated in various tissues of the slab head phantom for different
energy beams with the goal that the proton Bragg peaks fall
inside the brain tissue. The method of changing the beam
energy depends on how the proton beam is generated. If a
synchrotron is used, the energy can be changed dynamically,
whereas in cyclotrons, energy may be changed by employing
an energy selection system that is a set of energy degraders
with different thicknesses. The ratio of the Bragg peak in
depth dose proﬁles depends on the method used to change the
beam energy. In the latter, some of the particles are removed
from the beam as a result of scattering in the mechanical
rang-shifters; for peaks with smaller depth, corresponding
to thicker degraders, the height decreases; whereas, for the
former, any increase in energy causes the energy and the range
straggling to increase. Therefore, the width of the Bragg peaks
increases for deeper seated peaks and, as a result, the height
decreases. We  considered a system in which the beam energy
was changed dynamically. Using a mathematical algorithm,
with the pristine dose proﬁles obtained from simulations for
different beam energies as its input, the weight for each pris-
tine peak was calculated in such a way that the spread out
Bragg peak (SOBP) was reproduced longitudinally, and a ﬂat
dose distribution in the depth of the target volume was gener-
ated. Acquiring proper weight for each pristine peak is based
on solving a set of linear equations explained by authors, in
a yet-to-be-published work, to design a range modulator for
a passive beam line. For a better conformation of the dose60.2 – 0.1 0.2 0.3 0.2 0.2
43.5  17.6 0.1 8.1 0.3 – –
71.2 – 0.2 0.4 0.2 0.3 0.2
distribution with the target tumor, and sparing critical tis-
sues in its proximity, it is essential to have the precise results
for pristine depth dose proﬁles and the width of each peak.
Our calculations show that to have a nearly uniform dose dis-
tribution in the tumor region using a typical spot scanning
system, the beam displacement, both in traverse and depth,
should be linked to the beam energy or, in other words, to the
peak position.24 For example, if the center of a typical tumor is
placed 2 cm deep inside the brain, corresponding to the peak
position of 70 MeV protons, to have a good modulation along
the depth, the adjacent layers should be 0.5 mm apart (the
average standard deviation of peak positions affect the modu-
lated proﬁle). If the tumor is located in a depth corresponding
to 100 MeV protons, this distance should be 1.2 mm (average
standard deviation of the peaks) to have uniform SOBP without
ripples in dose distribution.
Secondary particles produced in the body of the patient,
can impact the organs near the target region, and contribute
substantially to the equivalent dose, whereas, those created in
the delivery beam line, inﬂuence the whole body and affect the
effective dose.25 The secondary photon and neutron produc-
tions were studied along with the amount of energy escaped
with these particles from the head. These are the main sources
of secondary particles in the organs near the target volume in
a typical scanning system. Finally, the energy spectra of these
particles were determined.
3.3.  MCNPX
The Monte Carlo simulations were performed using MCNPX
(Monte Carlo N-Particles eXtension) code version 2.4 which is
a modern, general-purpose Monte Carlo code developed at Los
Alamos National Laboratory in USA.26 MCNPX is the extension
of MCNP code which is capable of tracking nearly all particles
at nearly all energies. MCNPX utilizes the latest nuclear cross
section libraries and uses physics models for particle types
and energies where tabular data are not available. Several tally
cards can be used to score different physical quantities. The
tally results are tabulated in the pair of mean and relative
errors.27
In the MCNPX, the energy of the residual nuclei and the
non-traced particles are considered to be deposited locally at
the point of production. To have more  accurate results, one
should track all particles that are predicted to be produced. In
our simulations, protons, neutrons, photons, deuterons, tri-
tons, helium-3 ions, and alpha particles were transported.
As for the cutoff energies, for being as precise as possi-
ble, they were set to the minimum values that can be traced
in MCNP, i.e.; 1 MeV for protons, and 1 keV for electrons,
positrons, and photons. As soon as a particle’s energy falls
below the cutoff, the transport simulation is terminated and
reports of practical oncology and radiotherapy 1 9 ( 2 0 1 4 ) 376–384 379
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Fig. 2 – Pristine depth dose proﬁles in the slab head
phantom for incident pencil beams with the energy range
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Fig. 3 – The absorbed depth dose proﬁle and averaged LET
dose level, the (80–20%) penumbra that identiﬁes the fall in the
distal region, and a practical range in which the dose falls into
10% of 100% dose level, are shown in Fig. 4. These weighs were0–145 MeV.
ll its remaining kinetic energy is deposited locally. We used
he mesh tally type 3, and for some results the +F6 heating
ally, to obtain volume-doses, or the depth dose proﬁles. By
hese tallies, the energy deposition by all charged particles,
eavy nuclei, and energy deposited locally for particles created
ut not tracked, are scored. The mesh tally gives the energy
eposition averaged over the volume, not the mass. Therefore,
he mesh tally result should be divided by tissue densities to
hange the tally result to the dose.
.  Results  and  discussion
.1.  Depth  dose  calculation
he calculated results of depth dose proﬁles for proton beams
ith 10-MeV steps and energy range 40–160 MeV in the
hantom are shown in Fig. 2. It can be seen that, for this
rrangement, the Bragg peaks fall inside the brain. All energy
nd dose calculations were carried out until the errors shrank
o less than 0.1%, achieved for about 2 million particles.
Depth dose proﬁle and dose average linear energy transfer
LET) of 100 MeV  proton beam are shown together in Fig. 3. LET
ncreases with depth like absorbed dose and the upswing in
he LET curve appears at a depth slightly greater than that of
he dose curve and goes slightly beyond the dose peak. This
s due to the fact that at the end of proton range, the aver-
ge stopping power and, hence, the LET, increase as a result
f decrease in the particle energy. On the other hand, some
articles disappear in this region and, as a consequence, the
ose, that is the product of particle ﬂuence and stopping power
ivided by organ density, decreases, and the depth dose pro-
le is in its distal region. This causes a very slight extension
f the iso-effective dose beyond the physical dose.
We  considered a typical tumor with the same composition
f the brain tissue, spreading 2 cm inside the brain along the
eam, with its center seated in a depth corresponding to thefor 100 MeV  proton pencil beam.
100 MeV protons that means around 5 cm depth in the brain.
Now, the goal is to come up with a ﬂat dose region in the
volume of interest. To achieve this, after establishing peak
positions and range stragglings for different beam energies
and proper ﬁtting, appropriate beam energies that may cause
an approximately ﬂat dose distribution in the desired volume,
were determined.22 The energies ranged from 92.1 MeV  to
108.0 MeV in 18 steps. The weight of each pristine depth dose
proﬁle was also obtained to create the SOBP in the depth of the
tumor. On the basis of the calculated weight for each energy,
one can say that the average proton energy is 103.6 MeV.  The
modulated proﬁle with the modulation width of about 2 cm,
along with the weighted pristine depth dose proﬁles, is shown
in Fig. 4.
Characteristics of this proﬁle, such as 95% modulation
(M95) which is the distance between two points in proximal
and distal regions where the dose falls to the 95% of 100%Fig. 4 – The expected SOBP proﬁle along with all the
weighted pristine depth dose proﬁles.
380  reports of practical oncology and rad
Fig. 5 – The 2D dose distribution contour for a 100 MeV
proton pencil beam in a typical spot scanning system. The
absorbed dose is in nGy.
implemented in the MCNPX input ﬁle to simulate and obtain
the dose distribution in the phantom. The two dimensional
(2D) dose distribution for a 100 MeV  mono energetic proton
beam, and the modulated proﬁle are shown in Figs. 5 and 6,
respectively, for a typical spot scanning system.
The role of the intensity modulated beam to spread out
the Bragg peak longitudinally in the tumor volume is seen
in Fig. 6. Indeed, by altering the beam energy with weighted
intensity, one layer of the tumor is scanned each time. As
Fig. 6 – The 2D dose distribution contour for a modulated
proﬁle in a typical spot scanning system. The absorbed
dose is in nGy.iotherapy 1 9 ( 2 0 1 4 ) 376–384
mentioned before, the distance between neighboring lay-
ers should be chosen in proportion to the distal fall of the
pristine proﬁles which depend on energy. This links the “layer-
interval” to the modulation range position for a dynamical
energy change in a spot scanning system. This, does not apply
to passive scattering beam lines, or active beam lines that use
an energy selection system (set of degraders) to adjust the
beam energy; particles meet approximately the same tissue-
equivalent-range, and experience a similar range straggling
and, hence, all pristines have the same peak width. It is clear
that to broaden the dose pattern laterally, the spot should
move transversally in proportion to the lateral penumbra of
the lateral dose proﬁle.24
4.2.  Absorbed  energy
To evaluate the energy deposited in the brain region, monoen-
ergetic proton pencil beams were considered to irradiate a slab
head phantom. It was seen that beams with energies higher
than 140 MeV lost part of their energies in the organs after
the brain. Thus, it is expected that the energy deposit within
the brain increases up to the maximum, as the energy of the
incident beam is increased, and thereafter, due to protons pen-
etrating the organs after the brain, starts to decline. In Fig. 7a
the energy deposit in the brain region is shown. The 40 MeV
proton beam is not able to penetrate the brain tissue, but
for higher energies, the energy deposit in the brain increases
until going beyond the energy of ∼135 MeV,  this is shown in
Fig. 7b as percentage. At the optimum energy of ∼135 MeV,
there seems to be 89% of it deposited in the brain. Needless
to say, these ﬁgures depend on the location of the tumor. For
instance, if the tumor is located in the middle of the brain,
say 5 cm deep inside, a 100 MeV beam would be required to
place the Bragg peak at the same position; for this energy, the
energy deposit within the brain is about 80%. From an earlier
work of ours22 and the result just quoted, one can conclude
that with a 100 MeV proton pencil beam, a middle seated brain
tumor with lateral dimensions of about 5 mm can be well tar-
geted, and expect an energy deposition of 80% in the brain.
For the aforementioned intensity modulated proﬁle, an aver-
age of about 85.6 MeV  (82.6%) of proton energy is deposited in
the brain volume, out of which, 32.8 MeV is lost in the tumor.
For the SOBP proﬁle of Fig. 4, on average, 32% of the proton
energy is deposited in the tumor. For this proﬁle, the peak-
to-entrance ratio is 2.2, which is 2.7 times smaller than the
corresponding value for the 100 MeV beam energy.
Fig. 8a shows the energy deposition within various tissues
embedded in the slab head phantom, for proton pencil beams
of 70, 100, 130 MeV,  and also for the modulated proﬁle. The
percentage of deposited energy per source particle energy for
the tissues is shown in Fig. 8b. It is seen that for beams with
their Bragg peaks entirely inside the brain, the energy deposit
in the brain increases with the beam energy, and for tissues
located before (after) the brain, it decreases (increases).
The energy losses in the organs along the particle tracks
are shown in Fig. 9 as functions of incident beam energies
between 40 and 145 MeV. Fig. 10 shows the absorbed doses
(nGy/particle) for various organs along the particle tracks
versus the incident proton energy. It can be seen that by
increasing the beam energy, the energy deposition in the
reports of practical oncology and radiotherapy 1 9 ( 2 0 1 4 ) 376–384 381
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Fig. 7 – Variation of absorbed energy in brain, (a) absolute and (b) percentage; as functions of incident proton energy.
Fig. 8 – The absorbed energy (a) and percentage of the absorbed energy (b) in various tissues for three different beam
energies and for the modulated proﬁle along with the escaped energy by secondary particles.
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neutrons is almost 10 times greater than that of photons, and382  reports of practical oncology an
organs located before the brain decreases. Especially, for upper
part of the cranium this decrease in energy deposit is faster.
At similar conditions, for organs located after the brain, the
energy deposit does not show any noticeable change up to
∼140 MeV.  This conﬁrms the role of protons in the treatment
of deep-seated tumors.
4.3.  Production  of  secondary  neutrons  and  photons
Two most important secondary particles, i.e. neutrons and
photons, were paid special attention to in this study. All “non-
primary” particles are produced either by the interactions of
the primary protons, or by the interactions of the secondary
particles. In Fig. 11a and b the neutron and photon productions
per primary protons are shown, respectively, as functions
of proton energy. It is seen that by increasing beam energy,
the production increases. Neutron and photon productions at
Ep = 40 MeV,  rise from 0.27% and 1.60%, respectively, to 10.14%
and 9.10% at Ep = 140. For both curves, the calculated data are
well ﬁtted by quadratic functions whose constant parameters
are given as legends in the ﬁgures
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Fig. 12a shows the amount of energy escaped from the head
by neutrons and photons, and Fig. 12b shows the same results
in percentage. The quadratic function ﬁtted to the neutron
data is also given in Fig. 12b. While the escaped energy by  sec-
ondary photons has small variations with the incident proton
energy, this value for neutrons is strongly energy-dependent
with respect to the incident proton energy, and goes from zero
at 40 MeV to 2.44 at 145 MeV.
It is interesting to note that at all energies; the escaped
energy by photons from the head phantom is approximately
constant and about 0.10%. A closer look shows that it averages
0.16% with a standard deviation of 0.02%, whereas, for neu-
trons it changes from 0.02% at 40 MeV  up to 1.68% at 145 MeV.
Thus, we  can conclude that for proton beams with energies of
60 MeV and higher, the escaped energy by secondary neutrons
is larger than that of secondary photons. For high beam ener-
gies of around 120 MeV, the fraction of energy that escapes by40 50 60 70 80 90 100 110 12 0 13 0 140
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even becomes greater for higher proton energies. This justi-
ﬁes the vast number of studies and publications on secondary
neutrons compared to secondary photons.6,7,9,11,15,25,28 The
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Fig. 15 – Neutron population as a function of depth in theig. 13 – Neutron spectra produced by three different beam
nergies of 70, 100 and 130 MeV.
verall fraction of proton energy that escapes by secondary
eutrons and photons, range from 0.14% to 1.86% for incident
roton beam-energy range 40–145 MeV.  At energy of 110 MeV,
his ﬁgure is about 1.00%. For the modulated proﬁle, neutron
nd photon productions are 4.9% and 7.3%, respectively. Here,
he energy escape by neutrons is 0.53%, and 0.19 for photons.
Fig. 13 shows the energy spectra of neutrons produced per
ncident proton for three different beam energies of 70, 100
nd 130 MeV.  It is seen that the neutron spectra have relatively
arge peaks at low energies; however, the spectra tail to high
nergies with smaller intensities. Fig. 14 also shows the energy
pectrum of photon produced a 100 MeV  incident proton. The
haracteristic photon energies due to nuclear transitions of
adioactive atomic nuclei produced in the interactions, mostly
y the primary protons or other secondary particles produced
n the tissue, are illustrated in the ﬁgure.
The maximum non-elastic nuclear cross-section occurs at
bout 10–50 MeV.29 Thus, it is expected to see a maximum for
econdary particle population in the depth corresponding to
0–50 MeV,  as shown for neutrons in Fig. 15. Since the peaks
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ig. 14 – Spectrum of photons produced by 130 MeV  beam
nergy.head phantom.
appear when protons come to about 5–8 MeV,  the maximum
in the secondary population occurs just before the Bragg peak.
Substituting the phantom with a water tank of the same
dimensions, it is clear that the depth dose proﬁles affect as
a result of different composition and density. Using a water
tank, instead of the detailed phantom and for the tumor speci-
ﬁed in Fig. 4, the whole energy that escapes from the treatment
volume by secondary particles and goes to a region far from
it, decreases approximately 0.2 MeV.  It is clear that for tumors
seated deeper in the brain, the difference would be more than
this value.
5.  Conclusion
For the geometry of our choice, and proton pencil beams
of ∼40–140 MeV,  the Bragg peaks fall inside the brain tis-
sue. A typical SOBP proﬁle is created using proper mono
energetic proton pencil beams with their relevant weights. A
2D-intensity modulated dose distribution for a single spot is
obtained, and the portion of energy that is deposited in the
tumor is calculated. Energy deposition increases to a maxi-
mum value of about 90% at 135 MeV.  Energy depositions and
absorbed doses in different tissues located before and after
the brain were calculated. We obtained quadratic functions
with appropriate parameters for both neutron and photon sec-
ondary production. The fraction of energy escaped by photons
is approximately constant for all energies and has a mean
value of 0.16%, while for neutrons it changes as a quadratic
function of beam energy from 0.02% up to 1.68%. Our MC
results show that the escaped energy by neutrons at 145 MeV
incident proton beam is 2.44 MeV. It is shown that for high-
energy proton beams, most of the escaped energy from the
head is due to secondary neutrons. For instance, at about
120 MeV, the energy escaped by secondary neutrons is almost
10 times greater than that of photons. The overall fraction of
proton energy that escapes by secondary neutrons and pho-
tons is approximately 1% for incident proton beam of 110 MeV,
and 1.86% for 145 MeV protons.
d rad
r
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2384  reports of practical oncology an
Conﬂict  of  interest
None declared.
Financial  disclosure
None declared.
 e  f  e  r  e  n  c  e  s
1. Haberer T. Advances in charged particles therapy. In: Nuclear
physics in 21st century: Int. Nucl. Phys. Conf. INPC 2001. AIP Conf.
Proc., vol. 610. 2002. p. 157–66.
2. Perez CA, Mutic S. Advances and future of radiation oncology.
Rep Prac Oncol Radiother 2013;I8:329–32.
3. Kraft G. Tumor therapy with heavy charged particles. Prog
Part Nucl Phys 2000;45:S473–544.
4. Zietman A. Proton beam and prostate cancer: an evolving
debate. Rep Prac Oncol Radiother 2013;I8:339–42.
5. Taddei PJ, Markovic D, Fontenot JD, et al. Stray radiation dose
and  second cancer risk for a pediatric patient receiving
craniospinal irradiation with proton beams. Phys Med Biol
2009;54:2259–75.
6. Jiang H, Wang B, Xu XG, Suit HD, Paganetti H. Simulation of
organ speciﬁc patient effective dose due to secondary
neutrons in proton radiation treatment. Phys Med Biol
2005;50:4337–53.
7. Polf JC, Newhauser WD, Titt U. Patient neutron dose
equivalent exposures outside of the proton therapy
treatment ﬁeld. Radiat Prot Dosim 2005;115:154–8.
8. Xu XG, Bednarz B, Paganetti H. A review of dosimetry studies
on external beam radiation treatment with respect to second
cancer induction. Phys Med Biol 2008;53:R193–241.
9. Jarlskog CZ, Lee C, Bolch W,  Xu XG, Paganetti H. Assessment
of organ speciﬁc neutron doses in proton therapy using
whole-body age-dependent voxel phantoms. Phys Med Biol
2008;53:693–714.
0. Agosteo S, Birattari C, Caravaggio M, Silari M, Tosi G.
Secondary neutron and photon dose in proton therapy.
Radiother Oncol 1998;48:293–305.
1. Brenner DJ, Hall EJ. Secondary neutron in clinical proton
radiotherapy: a charged issue. Radiother Oncol 2008;86:165–70.2. Kim S, Byung JM, Yoon M, et al. Secondary radiation doses of
intensity-modulated radiotherapy and proton beam therapy
in patient with lung and liver cancer. Radiother Oncol
2011;98:335–9.
2iotherapy 1 9 ( 2 0 1 4 ) 376–384
3. National Research Council of the National Academies. Health
risks from exposure to low levels of ionizing radiation – BEIR VII.
Washington, DC: The National Academies Press; 2006.
4. Kellerer A, Rossi H. A generalized formulation of dual
radiation action. Radiat Res 1978;75:471–88.
5. Joiner MC, Field SB. The response of mouse skin to irradiation
with neutrons from the 62 MeV cyclotron at Clatterbridge,
UK. Radiother Oncol 1988;12:153–66.
6. Slopsema R. Beam delivery using passive scattering. In:
Paganetti H, editor. Proton therapy physics.  Boca Raton: CRC
Press/Taylor & Francis; 2011. p. 125–56.
7. Paganetti H. Dose to water versus dose to medium in proton
beam therapy. Phys Med Biol 2009;54:4399–421.
8. Torﬁmov A, Borfeld T. Beam delivery sequencing for intensity
modulated proton therapy. Phys Med Biol 2003;48:1321–31.
9. ICRU, International Commission on Radiation Units and
Measurements. Report 46: photon, electron, proton, and
neutron interaction data for body tissues. J ICRU 1992.
0. Eckerman KF, Cristy M, Ryman JC. The ORNL mathematical
phantom series; 1996. Available at: http://homer.ornl.gov/
vlab/mird2.pdf
1. Kooy HM, Clasie BM, Lu HM, et al. A case study in proton
pencil-beam scanning delivery. Int J Radiat Oncol Biol Phys
2010;76:624.
2. Pedroni E, Bacher R, Blattmann H, et al. The 200 MeV  proton
therapy project at the Paul Scherrer Institute: conceptual
design and practical realisation. Med Phys 1995;22(1):37–53.
3. Haberer Th Becher W,  Schardt D, Kraft G. Magnetic scanning
system for heavy ion therapy. Nucl Instrum Methods Phys Res A
1993;330:296–305.
4. Jia SB, Mowlavi AA, Hadizadeh MH, Ebrahimi Looshab M.
Range straggling and multiple scattering effects on brain
proton therapy. Int J Radiat Res 2014 (in press).
5. Schneider U, Agosteo S, Pedroni E, Besserer J. Secondary
neutron dose during proton therapy using spot scanning. Int J
Radiat Oncol Biol Phys 2002;53(1):244.
6. Waters LS, Hendricks J, McKinney G. MCNPX, Monte Carlo
N-particle transport code system for multiparticle and high energy
applications.  Los Alamos, NM: Los Alamos National
Laboratory; 2002.
7. Pelowitz DB, editor. MCNPXTM user’s manual, version 2.6.0. Los
Alamos, NM: Los Alamos National Laboratory; 2008.
LA-CP-07-1473.
8. Pérez-Andújar A, Newhauser WD, DeLuca PM. Neutron
production from beam-modifying devices in a modern
double scattering proton therapy beam delivery system. Phys
Med Biol 2009;54:993–1008.
9. ICRU, International Commission on Radiation Units and
Measurements. Report 63: nuclear data for neutron and
proton radiotherapy and for radiation protection. J ICRU 2000.
